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Muscular dystrophies are a heterogeneous group of disorders linked to defects in 20–30 different genes. Mutations in the genes encoding a pair
of nuclear envelope proteins, emerin and lamin A/C, have been shown to cause the X-linked and autosomal forms respectively of Emery–Dreifuss
muscular dystrophy. A third form of muscular dystrophy, limb girdle muscular dystrophy 1b, has also been linked to mutations in the lamin A/C
gene. Given that these two genes are ubiquitously expressed, a major goal is to determine how they can be associated with tissue specific diseases.
Recent results suggest that lamin A/C and emerin contribute to the maintenance of nuclear envelope structure and at the same time may modulate
the expression patterns of certain mechanosensitive and stress induced genes. Both emerin and lamin A/C may play an important role in the
response of cells to mechanical stress and in this way may help to maintain muscle cell integrity.
© 2006 Elsevier B.V. All rights reserved.Keywords: Muscular dystrophy; Nuclear envelope; Nuclear lamia; Laminopathy; Emerin1. Introduction
Muscular dystrophies (MDs) represent a diverse group of
several dozen inherited disorders [1]. While their common
feature is always progressive weakness and degeneration of
skeletal muscle, these various disorders may differ, quite
considerably, with respect to location of affected tissues,
disease progression and severity. Disparity in affected muscles
can easily be appreciated when comparing facioscapulohumeral
MD 1A (FSHMD1A OMIM #158900) to limb girdle MD 1A
(LGMD1A OMIM #159000). In the former, the muscle groups
affected are in the face, shoulder girdle and lower legs. In the
latter, proximal weakness of the hip girdle is observed which
only later progresses to the shoulder girdle. Other forms of
muscular dystrophy, for example Emery–Dreifuss MD (EDMD
OMIM #310300), may feature degeneration of cardiac muscle
in addition to skeletal muscle. Finally, certain forms of muscular
dystrophy such as EDMD may appear early in life whereas
others such as LGMD1A display an adult onset. Mutations in at
least 20–30 genes [2,3] have been associated with MD. Proteins
encoded by these genes can be grouped according to their
subcellular localization. While this review will focus primarily⁎ Corresponding author. Tel.: +1 352 392 0040; fax: +1 352 392 3305.
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doi:10.1016/j.bbadis.2006.06.001on MD-linked nuclear proteins, functional parallels between
protein groups will be explored.
2. Cytoskeletal and extracellular matrix related muscular
dystrophies
The most common form of MD is Duchenne MD (DMD
OMIM #310200) [1]. This is an X-linked disorder with an early
onset of about 3–5 years of age. The affected gene in DMD
encodes dystrophin, an extremely large (∼400 kDa) protein
related to alpha actinin and spectrin. In muscle cells, dystrophin
functions to link the actin cytoskeleton to the plasma membrane
and extracellular matrix (ECM) [2,3]. The N-terminus of
dystrophin interacts directly with cytoskeletal actin filaments,
but not actin filaments of the contractile apparatus. Distal
regions of the molecule bind a complex of plasma membrane
proteins containing, among others, members of the dystrogly-
can and sarcoglycan families of glycoproteins. Alpha-dystro-
glycan in turn binds to alpha2-laminin on the extracellular face
of the plasma membrane providing a link to the ECM. Perhaps
not surprisingly, mutations in the genes encoding dystroglycans,
sarcoglycans and laminin have all been linked to various forms
of muscular dystrophy [2,3]. In addition, forms of MD such as
Fukuyama congenital muscular dystrophy appear to involve
proteins that are implicated in the intracellular processing of
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all of these proteins have in common is their contribution to the
integrity of a structural network, with signaling properties, that
connects the muscle cell cytoskeleton to the ECM through the
plasma membrane. Other MD-associated genes encode cyto-
solic proteins like calpain-3 and sarcomeric proteins such as
titin. The latter functions both as a molecular ruler in sarcomere
assembly as well as an elastic component of the contractile
apparatus. In this way titin makes a direct contribution to
muscle cell functionality.
3. Nuclear envelope related muscular dystrophies
In recent years an additional group of MDs have been linked
to defects in nuclear envelope proteins [1]. The prototype of
these is Emery–Dreifuss MD. EDMD displays two inheritance
patterns, X-linked (EDMD OMIM #310300) and autosomal
(EDMD2 OMIM #181350). Both forms of the disease display
similar physical symptoms featuring degeneration of muscles of
the upper arms, shoulder girdle and lower legs, and contractures
of the Achilles tendons as well as of tendons of the elbows and
neck. These contractures have a childhood onset and are one of
the early signs of the disease. EDMD also features a very
significant cardiac involvement with both cardiac muscle
degeneration and associated conduction system block. The latter
frequently requires the implantation of a pacemaker in early
adulthood and may ultimately necessitate a heart transplant.
In 1994, the X-linked form of EDMD was mapped to a gene
encoding emerin, a 29 kDa membrane protein (named after
Professor Alan Emery, who originally described the disease [6])
[7]. Emerin immediately provided two surprises. First, it turned
out to be a nuclear envelope membrane protein and second it
was not specific to muscle [8,9]. Instead it is expressed in
virtually all human-cell types. Subsequent discussion will delve
further into the etiology of both X-linked and autosomal
EDMD, as well as other associated disorders, in an attempt to
elucidate how defects in ubiquitously expressed proteins might
give rise to tissue specific diseases. Finally, recent findings will
be examined which might functionally connect nuclear
envelope components with dystrophin and dystrophin asso-
ciated proteins (dytroglycans and sarcoglycans etc.) that are
linked to Duchenne, Becker and related forms of MD.
4. The nuclear envelope
The nuclear envelope (NE) is a selective barrier that forms
the interface between the nucleus and the cytoplasm, and as
such plays a central role in defining the biochemical identities of
each compartment [10,11]. In addition to its barrier function, it
is becoming increasingly clear that the NE is a key determinant
of nuclear architecture and may strongly influence cytoplasmic
organization. The NE contains several discrete structural
elements, the most prominent of which are the inner and outer
nuclear membranes (Fig. 1). In mammalian somatic cells these
two membranes are separated by a uniform gap of about 30–
50 nm referred to as the perinuclear space (PNS). The INM and
ONM are connected at annular junctions which create aqueouschannels between the nucleoplasm and cytoplasm. These
channels are occupied by nuclear pore complexes (NPCs),
massive multi-protein assemblies that regulate the trafficking of
macromolecules across the NE. A mammalian somatic cell
nucleus typically contains several thousand NPCs.
In addition to its continuities with the INM at the periphery
of each NPC, the ONM also displays multiple connections to
the peripheral endoplasmic reticulum (ER) to which it is
functionally related. Evidently the INM, ONM and ER form a
single continuous membrane system. Similarly, the PNS
constitutes a perinuclear extension of the ER lumen, and
contains both secretory proteins and soluble ER resident
proteins, including ER chaperones.
The final major structural feature of the NE is the nuclear
lamina [12]. This is a relatively thin (20–50 nm) protein
meshwork that is closely associated with both the nuclear face
of the INM and the underlying chromatin. The key components
of the nuclear lamina are a group of proteins known as A- and
B-type lamins. The lamin proteins are members of the more
extensive cytoplasmic intermediate filament (IF) family and like
all IF proteins contain a central coiled-coil domain flanked by
non-helical head and tail domains. In contrast to their
cytoplasmic counterparts, each of the lamins contains a nuclear
localization sequence (NLS) within the C-terminal non-helical
domain required for efficient nuclear import of newly
synthesized lamin proteins. Both A- and B-type lamins are
known to interact with membrane proteins of the INM [12] as
well as with chromatin [13,14]. In this way, the nuclear lamina
may provide anchoring sites at the nuclear periphery for higher
order chromatin domains in addition to stabilizing and
organizing the NE. While the bulk of the lamins appear to
reside at the nuclear periphery, nucleoplasmic lamins have also
been observed [15–17] with proposed roles in several aspects of
nuclear metabolism, including DNA replication [18–21].
In mammalian cells there are two major A-type lamins, A
and C, encoded by a single gene, LMNA [22]. These two
proteins are identical for the first 566 amino acid residues. Both
proteins possess unique C-terminal extensions. In the case of
lamin C this consists of a sequence of six amino acids. The
unique region of lamin A is considerably larger at 98 amino
acids. Two other A-type lamins have been described. The first
of these, lamin AΔ10 [23], lacks a 30 amino acid sequence
within the unique lamin A specific region that is encoded by
exon 10 (LMNA contains 12 exons). While it is found in somatic
cells, its abundance and distribution has yet to be well defined.
Lamin C2 [24] is male germ cell-specific and essentially
consists of a truncated form of lamin C that contains an
alternative N-terminus modified by myristoylation.
Mammalian somatic cells also contain two B-type lamins,
lamins B1 and B2 [25], encoded by separate genes (LMNB1 and
LMNB2) [26,27]. A third B-type lamin, lamin B3, derived from
the LMNB2 primary transcript by alternative splicing is male
germ cell-specific [28]. While B-type lamins as a class are
expressed in all nucleated cell types, the expression of A-type
lamins is developmentally regulated [29,30]. As a general rule,
A-type lamins are found in most adult differentiated cell types
but are absent from both early embryonic cells and adult stem
Fig. 1. Overview of the organization of the nuclear envelope. Several selected protein components are shown. These include the nuclear lamina composed of lamin
oligomers, and both inner and outer nuclear membrane (INM and ONM) proteins. INM proteins include lamin B receptor (LBR), lamina associated proteins 1 and 2
(LAP1 and LAP2), MAN1, emerin and Sun1. The latter acts as a tether for Nesprin 2 in the ONM through interactions which span the perinuclear space (PNS). The
latter is continuous with the ER lumen. Soluble proteins, heterochromatin protein 1 (HP1) and barrier to autointegration factor (BAF) interact with the nucleoplasmic
domains of certain INM proteins and provide a link for chromatin domains at the NE. Chromatin domains are also anchored to the nuclear lamina.
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commences only midway through gestation at embryonic day 8
or day 9, initially in cells of the trophoblast and visceral
endoderm [29].
The ubiquitous expression of B-type lamins led to the
conclusion early on that these were essential proteins. This has
certainly turned out to be true of lamin B1, at least at the
organismal level. Gene targeting experiments in mice have
revealed that lamin B1 is required for the development of viable
embryos [33]. However, mouse embryonic fibroblasts derived
from Lmnb1-null embryos can nevertheless be maintained in
culture. Evidently this protein is dispensable in certain cell
types. This observation is supported by findings that HeLa cells
depleted of lamin B1 [34] and/or lamin B2 using RNA
interference continue to proliferate in culture, at least in the
short term (Kyle Roux, Melissa Crisp and Brian Burke,
unpublished observations).
Lamin A and lamins B1 and B2, feature C-terminal CaaX
motifs (whereC is cysteine, a is an aliphatic amino acid andX is
usually a hydrophobic residue). The CaaX motif was originally
described in small Ras-related GTPases and represents a site of
farnesylation [35]. This modification is mediated by a protein
farnesyl transferase and occurs on the CaaX cysteine residue
soon after completion of lamin synthesis [36–39]. Farnesylation
is followed by C-terminal proteolysis to remove the aaX
residues [40]. Processing of the CaaX motif is then completed
by carboxy methylation of the newly exposed C-terminal
cysteine residue [40]. Farnesylation of the CaaX cysteine
residue is a prerequisite for the efficient assembly of newly
synthesized lamins into the interphase nuclear lamina [41–43].While the B-type lamins remain permanently farnesylated,
lamin A is unique in that this modification is lost following
proteolytic cleavage 14 residues upstream from the farnesy-
lated cysteine [44]. This cleavage event is catalyzed by
ZmpSte24, a membrane associated proteinase [45,46], and
occurs soon after incorporation into the nuclear lamina,
typically within 30–60 min of synthesis [47]. In this way,
full length, or pre-lamin A exists only transiently in normal
cells.
While individual lamin monomers are known to assemble to
form coiled-coil homodimers, the higher order organization of
the lamina is still a topic of considerable debate. As members of
the IF family, the lamins are thought to be organized in the form
of filaments. Certainly this has been borne out in ultrastructural
studies of Xenopus oocyte nuclear envelopes where the lamina
appears as an oftentimes orthogonal meshwork of 10 nm
filaments [48]. However, the oocyte lamina is composed
primarily of a single lamin isoform (lamin L3) [49]. The
organization of the more complex mammalian somatic cell
lamina containing lamins A, C, B1, B2 and perhaps AΔ10, has
yet to be satisfactorily addressed.
5. Nuclear membrane proteins
Despite their numerous connections at the periphery of each
NPC, the INM and ONM are biochemically quite distinct. This
could be surmised even from early ultrastructural studies since
the ONM, but not the INM, contains numerous bound
ribosomes. Recent proteomic studies have revealed the
existence of as many as 67 integral membrane proteins that
Fig. 2. Sun1 protein dimers in the inner nuclear membrane (INM) function as
tethers for nesprin proteins in the outer nuclear membrane (ONM). Dimerization
of Sun1 is likely mediated by an extended coiled-coil domain within the
perinuclear space (PNS). The nucleoplasmic domain of Sun1 binds farnesylated
pre-lamin A. The cytoplasmic domain of nesprins 1 and 2 interacts with actin
filaments whereas that of nesprin 3 binds plectin. The latter is likely to provide a
link to the cytoplasmic intermediate filament (IF) network.
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the INM [50]. The mechanism by which proteins become
localized to the INM has been a topic of some debate. The
consensus that has emerged is that it involves, at least in part, a
process of selective retention [51–53]. In this model, proteins
that are synthesized on the peripheral ER or ONM gain access to
the INM by lateral diffusion via the membrane continuities
surrounding each NPC. Only proteins that can interact with
nuclear, other INM or lamina components will be retained and
concentrated. However, recent findings that movement of
membrane proteins between the ONM and INM involves an
energy dependent mechanism [54] and which appears to operate
at the level of the NPC, suggest that we have not yet heard the
final word on INM protein sorting.
The recent identification of a number of ONM-specific
integral membrane proteins has raised additional questions [55–
57]. In particular, what prevents ONM proteins from simply
drifting away into the peripheral ER? The issue of ONM protein
localization was originally addressed in C. elegans. Starr and
Han [58] demonstrated that the appropriate localization of Anc-
1, a very large type II ONM protein involved in actin-dependent
nuclear positioning, was dependent upon Unc-84, an INM
protein [58]. Localization of Unc-84 itself was found to be
dependent upon the single C. elegans lamin [59]. Based upon
these and similar findings, both Lee et al. and Starr and Han
[59,60] proposed a model in which Unc-84 and Anc-1 would
interact across the PNS via their respective lumenal domains. In
this way, Unc-84 would act as a trans-lumenal tether for Anc-1
in the ONM.
In mammalian cells two giant (800–1000 kDa!) actin
binding proteins have been identified (variously termed
NUANCE, nesprin 2 Giant, nesprin 1, enaptin, Syne 1, syne
2, myne 1) as integral proteins of the ONM [55–57,61,62]. Due
to a complex array of alternatively spliced isoforms a very large
family of proteins are encoded by the nesprin 1 and nesprin 2
genes [56]. Nesprins are related to Anc-1, as well as to a Dro-
sophila ONM protein known as Klarsicht [63–66]. All three
proteins contain an ∼60 amino acid C-terminal KASH domain
(Klarsicht, Anc-1, Syne Homology) that is comprised of a
single transmembrane anchor and a short segment of about 40
residues that resides within the PNS.
A third nesprin family member, nesprin 3, has also been
described [67]. Like nesprins 1 and 2, nesprin 3 possesses a C-
terminal KASH domain. However, its distinct N-terminal
cytoplasmic domain features a binding site for plectin, a very
large (466 kDa) intermediate filament-associated protein. Thus,
whereas nesprins 1 and 2 connect the NE to microfilaments,
nesprin 3 may function as a link between the NE and the
cytoplasmic intermediate filament network.
One of the defining features of the C. elegansUnc-84 protein
is a 200 amino acid region of homology with Sad1p, an S.
pombe polypeptide that is associated with the spindle pole body
[68]. This region of homology is known as the SUN domain (for
Sad1p, UNc-84) and extends into the PNS. Mammalian cells
contain several SUN domain proteins. Indeed there are five that
are encoded within the human genome. Two of these, Sun1 and
Sun2, are INM proteins and have a topology similar to that ofUnc-84 with a nucleoplasmic N-terminal domain and a C-
terminal SUN domain in the PNS [69–71]. At least in the case
of Sun1, its nucleoplasmic domain interacts with farnesylated
pre-lamin A raising the possibility that this protein could
function in lamin A targeting and/or assembly [69].
Recent reports indicate that both Sun1 and Sun2 cooperate in
tethering nesprin 2 Giant (nesp2G) within the ONM [69,72].
This tethering involves the establishment of molecular interac-
tions that span the PNS [73] similar to that suggested for Anc-1
and Unc84 in C. elegans (Fig. 2). Circumstantial evidence
based upon competition between nesprin 1 and nesprin 2 KASH
domains indicates that nesprin 1 Giant (nesp1G, enaptin) is
similarly tethered by Sun1 and Sun2. It follows, therefore, that
Sun1 and Sun2 function as links in a molecular chain that
connects the actin cytoskeleton, via giant nesprin proteins, to
nuclear lamins and other components of the nuclear interior. We
now refer to this assembly as the LINC complex (for LInker of
Nucleoskeleton and Cytoskeleton) [69]. The recent discovery of
nesprin 3 as a link to the IF system [67], suggests that there
maybe multiple functionally distinct isoforms of the LINC
complex that are responsible for integrating the nucleus with
different components of the cytoskeleton. The implication of the
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cytoplasm may display interdependent mechanical properties.
As will be discussed below, this has recently been shown to be
the case.
6. The nuclear envelope and muscular dystrophy
X-linked EDMD was the first human disorder to be linked to
defects in a component (emerin) of the NE. Emerin is a type II
transmembrane protein that localizes exclusively to the INM
[7–9]. The bulk of its mass resides within its 220 amino acid N-
terminal nucleoplasmic domain. The majority of emerin
mutations, either point or nonsense mutations, that are
associated with EDMD lead to complete loss of the emerin
protein or to its mislocalization [74–77]. It would appear that
EDMD must be caused by loss of some essential emerin
function. The nature of this function, however, is still a matter of
debate. Although emerin is expressed in the majority of adult
cell types, only skeletal and cardiac muscle seem to be
adversely affected by its loss.
Detailed analyses of the emerin protein both in vivo and in
vitro have revealed that the nucleoplasmic domain of emerin
interacts with multiple nuclear proteins [78–82]. The N-
terminus of emerin shares a sequence of about 40 amino acids
with several other proteins including the INM proteins lamina
associated polypeptide 2 (LAP2) and MAN1. This region of
homology, known as the LEM domain (for LAP2, emerin and
MAN1) functions as a binding site for BAF (barrier to
autointegration factor) a small DNA binding protein [83,84].
In this way BAF functions as a link between emerin and
chromatin. Emerin also binds to several transcriptional
regulators, germ cell less (GCL) [80] and Btf [78]. Binding of
GCL and BAF to emerin are mutually exclusive [80]. Btf when
overexpressed induces apoptosis. Thus sequestration of Btf by
emerin could potentially have an anti-apoptotic function. In
terms of regulatory activities, emerin might also modulate pre-
mRNA processing through interactions with YT521-B, a factor
involved in splice site selection [82].
In addition to these regulatory molecules, emerin interacts
with a number of structural proteins including actin and A-type
lamins. Emerin has been shown to promote the polymerization
of actin and to cap the pointed end of actin filaments in vitro. It
likely binds nuclear actin in vivo. As will be described further
below, the interaction with A-type lamins contributes to the
appropriate localization of emerin to the INM.
Studies on the role of emerin in vivo have so far shed only a
little light on the etiology of X-linked EDMD. In C. elegans,
depletion of the emerin orthologue by RNA intereference yields
no detectable phenotype [85]. Emerin depletion is however,
synthetic lethal with depletion of MAN1, which like its
mammalian orthologue, is also a LEM domain protein [85].
Mice harboring a deletion of the emerin gene have no overt
symptoms of muscular dystrophy and display no obvious
skeletal or cardiac muscle pathology [86]. However, in common
with human EDMD patients, fibroblasts derived from emerin
deficient mice often have irregularly shaped nuclei featuring
blebbing of the nuclear membranes [87]. Furthermore, emerindeficient fibroblasts exhibit impaired signaling responses to
mechanical stress. This may be observed in terms of reduced
induction of iex-1 and egr-1, a pair of mechanosensitive genes
[87]. The overall effect is that emerin-null cells, when compared
with wild type cells, display increased rates of apoptosis when
subjected to mechanical strain [87].
Several years after the identification of the emerin gene as
the site of mutations causing X-linked EDMD, the autosomal
dominant form of the disease was mapped to the LMNA gene
[88]. Soon thereafter, limb girdle MD 1B (LGMD1B) and
dilated cardiomyopathy (DCM) were also linked to mutations in
LMNA [89,90]. In total more than 70 distinct mutations within
LMNA have now been linked to skeletal and cardiac muscle
diseases (Fig. 3). A few rare mutations which cause autosomal
recessive EDMD have also been mapped to LMNA.
Muscular dystrophy (EDMD and LGMD1B) and cardio-
myopathy are only three of at least 11 (depending upon
definition) other disorders linked to mutations in the LMNA
gene [91]. These diseases, which are commonly referred to as
“laminopathies”, include Dunnigan type familial partial lipo-
dystrophy (FPLD) [92,93], Charcot–Marie–Tooth disease
(CMT2) [94], mandibuloacral dysplasia (MAD) [95], restrictive
dermopathy (RD) [96] and two premature aging syndromes,
Hutchinson–Gilford progeria (HGPS) [97–99] and atypical
Werner's syndrome (aWRN) [100,101]. A major goal now is to
determine how mutations in the widely expressed LMNA gene
can give rise to such a bewildering array of tissue specific
disorders. What is becoming increasingly clear is that multiple
disease mechanisms must be at work [12,102,103]. A complete
discussion of the laminopathies is beyond the scope of this
review. therefore the remainder of the article will focus
primarily on the molecular causes of EDMD, LGMD1B and
DCM.
Dilated cardiomyopathy is a feature of both EDMD and
LGMD1B. These two disorders differ only in terms of the
affected muscle groups (e.g. distal versus proximal leg
muscles). Evidently, certain LMNA mutations may cause heart
disease (DCM) but spare skeletal muscle. However, either
additional genetic or environmental factors may tip the balance
towards skeletal muscle involvement [104]. This view is
supported by observations of Brodski et al. who have identified
a family carrying a single lamin A mutation (a frameshift caused
by a single nucleotide deletion at position 959) where different
members have been diagnosed with EDMD, LGMD or with
DCM [105]. The bulk of LMNA mutations associated with
muscle disease involve single amino acid changes, although
deletions, frameshifts (above) and nonsense mutations are well
represented (Fig. 3). Indeed the earliest report linking LMNA to
autosomal dominant EDMD highlighted a nonsense mutation at
codon number six [88]. This would in effect represent a
functional gene deletion, thus LMNA haploinsufficiency is
sufficient to cause muscle disease.
Mutations associated with muscle disease are found
throughout the LMNA gene, including many in exons encoding
the coiled-coil domain. These may prevent dimer formation or
alter lateral interactions between A-type lamins thereby
interfering with the assembly of higher order lamin structures.
Fig. 3. Myopathy related mutations within human lamin A. The position and nature of EDMDmutations are indicated by blue boxes. Dilated cardiomyopathy (DCM)
mutations are indicated in orange. LGMD1B mutations are indicated in purple. Substitutions are in single letter code. X represents a nonsense mutation, fs refers to a
frameshift and a deletion is indicated by Δ. The lamin A central coiled-coil domain is shaded in dark blue, while the C-terminal CaaX box is in green. This figure was
compiled from the Leiden University muscular dystrophy pages and lamin A/C sequence variation database (http://www.dmd.nl/lmna_seqvar.html).
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disease-linked lamin mutations cause abnormalities in A-type
lamin assembly at the nuclear periphery [106–108]. The non-
helical lamin A tail is known to be comprised in part by an
immunoglobulin type fold consisting of apposed beta sheets
[109,110]. Those EDMD-associated mutations found in this
region of the lamin A molecule are predicted to significantly
disrupt the 3D organization of the Ig domain. Taken together,
these observations are consistent with the notion that muscle
pathologies are linked to loss of structurally functional lamin
proteins.
Homologous recombination has been used to eliminate the
Lmna gene in mice [111]. Animals homozygous for the deletion
are born without any striking abnormalities, indicating that A-
type lamin expression is not a prerequisite for normal
embryonic development. However, newborn Lmna-null mice
fail to thrive and display clear evidence of muscle weakness.
Histological analyses reveal extensive muscular dystrophy and
cardiomyopathy. These animals, which never survive beyond
eight weeks of age, display a syndrome that is very similar to
human EDMD. There are, however, two important differences.
The first is that Lmna-null mice display a peripheral axonal
neuropathy similar to CMT2 (in humans this is caused by an
R298C mutation) [112]. There is no evidence of any other
laminopathy-related pathology in these knock out animals.
Secondly, heterozygous animals (Lmna+/−) are asymptomatic
[111]. As described above, loss of just one LMNA allele in
humans is associated with EDMD. Regardless of these
differences, however, the mouse studies lend considerable
support for the view that it is loss of A-type lamin function that
underlies the skeletal and cardiac muscle pathologies.
At the cellular level, loss of A-type lamin expression is
associated with prominent changes in nuclear morphology
[111]. In both fibroblasts from Lmna-null mice as well as cellsfrom laminopathy patients [113], nuclei are frequently observed
to have highly irregular shapes. This is usually associated with
the appearance of NE “herniations” in which B-type lamins,
INM proteins, NPCs and chromatin are withdrawn from one
pole of the nucleus. This is accompanied by localized dilation of
the ONM in the NPC free regions. Changes in heterochromatin
organization, particularly loss of peripheral heterochromatin,
are also observed [114]. Given that heterochromatin is generally
transcriptionally silent, loss of A-type lamins could be
associated with changes in gene expression patterns.
A final conspicuous feature of fibroblasts derived from
Lmna-null mice is the frequent mislocalization of emerin from
the INM to the peripheral ER [111]. Introduction of human
lamin A in to these cells by transfection will restore the normal
localization of emerin to the INM. Similar mislocalization of
emerin can be observed in HeLa cells following depletion of A-
type lamins by RNA interference [34]. These observations
clearly demonstrate that A-type lamins contribute to the normal
localization of emerin and provide a molecular relationship
between X-linked and autosomal EDMD.
Mutations of titin are associated with multiple MD disorders
where conventional thought suggests its role as a structural
protein of the muscle sarcomere is presumably disrupted [115].
However, a recent report by Zastrow et al. identified nuclear
titin as a binding partner for A- and B-type lamins [116],
making titin the third NE protein mutated in MD. It remains to
be seen if perturbation of titin function at the NE might underlie
some aspects of disease pathology within muscle cells.
At present there are two views of how defects in NE proteins
might give rise to skeletal and cardiac muscle disease, and
involve either mechanical stress or gene expression based
models [102,117]. As will be seen, however, these views are not
mutually exclusive. The mechanical stress model proposes that
muscle cell nuclei lacking functional A-type lamins or emerin
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repeated cycles of muscle contraction. This notion has some
merit. Firstly, we know that nuclei containing either defective
A-type lamins or depleted of A-type lamins exhibit structural
abnormalities. Furthermore, nuclei isolated from Lmna-null
mouse livers are far more prone to fragmentation than their
wild-type derived counterparts [111]. Recently Lammerding et
al. [118] and Broers et al. [119] have demonstrated exactly such
nuclear fragility in Lmna-null fibroblasts in vivo. Basically
these investigators used direct mechanical methods to deform
nuclei in cells in culture. They were able to show that the nuclei
in Lmna-null fibroblasts were more deformable and ruptured
under lower applied forces than nuclei in wild-type fibroblasts.
Lammerding et al. also demonstrated that the cytoplasm of
Lmna-null cells was mechanically less resilient than that of
wild-type cells [87]. This begins to make some sense given that
we now know that nuclei are coupled to both the actin and IF
cytoskeleton via the LINC complex of SUN proteins and
nesprin proteins [56,57,67,69,72]. In muscle cells actin
filaments and desmin IF filaments are linked to dystroglycans
and sarcoglycans at the cell surface via contacts with dystrophin
and other dystrophin interacting proteins. This raises the
possibility that in EDMD and related myopathies, mechanical
stress might have detrimental effects on both nuclear and
cytoplasmic (and perhaps plasma membrane) organization. In
this respect, the etiology of EDMD could have more in common
with that of Duchenne and related MDs than immediately meets
the eye.
The alternative view of EDMD, LGMD1B and DCM
pathology proposes that changes in NE organization due to
emerin or lamin mutations might lead to changes in muscle cell
gene expression patterns. Both emerin and A-type lamins are
known to interact with a number of transcriptional regulators
including GCL and Btf (in the case of emerin) [78,80] and
SREBP [120], Rb [121] and MOK2 (in the case of lamin A)
[122]. Furthermore, the well documented rearrangements in
heterochromatin organization would be entirely consistent with
this idea. Compelling evidence in favor of the gene expression
model comes from several quarters. As described above, emerin
deficient mice exhibit no overt pathology. However, muscle
regeneration in these mice show clear abnormalities. In
particular, myogenic differentiation is delayed, a phenomenon
that is associated with perturbations in transcriptional pathways
that are regulated by Rb and MyoD [86]. Similarly, lamin A
mutants have been found to interfere with the differentiation
program of C2C12 myoblasts [123,124].
Both mechanical stress and gene expression defects may be
integrated in other observations. Lmna-null fibroblasts exhibit
grossly impaired mechanotransduction and decreased viability
under mechanical strain [118,119]. Induction of the mechan-
osensitive genes, iex-1 and egr-1 is strongly attenuated [118].
Similar but milder effects are observed in emerin-null cells [87].
Lmna-null cells (but not emerin-null cells) also exhibit reduced
NF-κB-regulated transcription in response to either cytokine or
mechanical stimulation [118]. Taken together, all of these
observations suggest that emerin- and Lmna-null cells exhibit
reduced viability when subjected to mechanical stress. Thisreduced viability may be due to direct mechanical effects (i.e.,
physical damage), inability to induce mechanosensitive genes or
indeed to both. In this way both the mechanical stress and gene
expression models may accurately describe different aspects of
the molecular basis of EDMD and related myopathies.
Clearly we have come a considerable way in improving our
understanding of NE biology since the original realization that
X-linked EDMD was caused by defects in an INM protein.
However, the recognition that at least nine or ten more human
diseases are linked to defects in A-type lamins has raised
puzzling questions. How for instance can defects in a near
ubiquitously expressed gene give rise to such an array of tissue
specific phenotypes? The answer may well lie with other
proteins that are themselves expressed in a tissue specific
fashion but which interact with A-type lamins. Some such
proteins may be represented among the sixty or more nuclear
membrane proteins identified using proteomics approaches.
Given the role of the LINC complex in integrating the nucleus
with the cytoskeleton a better understanding of some lamino-
pathies may even arise through studies of NE-associated
cytoplasmic proteins. What is certain is that this area of
research at the interface of medicine and cell biology will
continue to present us with surprises that redefine our under-
standing of cellular structure and function while hopefully
revealing novel avenues for disease therapy.References
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